Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Developing potential cellular and gene therapy products – frequently asked questions (from Catapult’s regulatory round-up for November 2024)

The FDA has issued a draft guidance intended to provide industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy products. Comments are due by 18th February 2025.

Published on the 3rd of december 2024. Read the entire Regulatory Round-up – November 2024 here.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (12 février 2025). Developing potential cellular and gene therapy products – frequently asked questions (from Catapult’s regulatory round-up for November 2024). ELSIBI. Consulté le 18 mars 2025 à l’adresse https://doi.org/10.58079/13axo


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.